BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32890260)

  • 21. Inflammation in Salt-Sensitive Hypertension and Renal Damage.
    Lu X; Crowley SD
    Curr Hypertens Rep; 2018 Oct; 20(12):103. PubMed ID: 30377822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune system in hypertension.
    Harrison DG
    Trans Am Clin Climatol Assoc; 2014; 125():130-38; discussion 138-40. PubMed ID: 25125726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure.
    Bansal SS; Ismahil MA; Goel M; Patel B; Hamid T; Rokosh G; Prabhu SD
    Circ Heart Fail; 2017 Mar; 10(3):e003688. PubMed ID: 28242779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal effects of cytokines in hypertension.
    Wen Y; Crowley SD
    Curr Opin Nephrol Hypertens; 2018 Mar; 27(2):70-76. PubMed ID: 29140820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of immune cells in hypertension.
    Caillon A; Paradis P; Schiffrin EL
    Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence.
    Caillon A; Schiffrin EL
    Curr Hypertens Rep; 2016 Mar; 18(3):21. PubMed ID: 26846785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.
    Ismahil MA; Hamid T; Bansal SS; Patel B; Kingery JR; Prabhu SD
    Circ Res; 2014 Jan; 114(2):266-82. PubMed ID: 24186967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Adaptive Immunity in the Development and Progression of Heart Failure: New Evidence.
    Sánchez-Trujillo L; Vázquez-Garza E; Castillo EC; García-Rivas G; Torre-Amione G
    Arch Med Res; 2017 Jan; 48(1):1-11. PubMed ID: 28577862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune mechanisms in hypertension.
    De Ciuceis C; Rossini C; La Boria E; Porteri E; Petroboni B; Gavazzi A; Sarkar A; Rosei EA; Rizzoni D
    High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):227-34. PubMed ID: 24446309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure.
    Afanasyeva M; Georgakopoulos D; Belardi DF; Bedja D; Fairweather D; Wang Y; Kaya Z; Gabrielson KL; Rodriguez ER; Caturegli P; Kass DA; Rose NR
    Proc Natl Acad Sci U S A; 2005 Jan; 102(1):180-5. PubMed ID: 15611472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell effects on T-cell effector pathways.
    Duffy MM; Ritter T; Ceredig R; Griffin MD
    Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune System and Microvascular Remodeling in Humans.
    Rizzoni D; De Ciuceis C; Szczepaniak P; Paradis P; Schiffrin EL; Guzik TJ
    Hypertension; 2022 Apr; 79(4):691-705. PubMed ID: 35098718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune mechanisms in arterial hypertension. Recent advances.
    Wenzel UO; Ehmke H; Bode M
    Cell Tissue Res; 2021 Aug; 385(2):393-404. PubMed ID: 33394136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune modulation of resistance artery remodelling.
    Schiffrin EL
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):70-2. PubMed ID: 21740527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
    Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling.
    Liu X; Shi GP; Guo J
    Front Cell Dev Biol; 2021; 9():659666. PubMed ID: 34368120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses to injury and their links to eye disease.
    Stepp MA; Menko AS
    Transl Res; 2021 Oct; 236():52-71. PubMed ID: 34051364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of T-cell activation in salt-sensitive hypertension.
    Ren J; Crowley SD
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1345-H1353. PubMed ID: 30901277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.